TCW Group’s GoHealth GOCO Stock Holding History

TCW Group’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41,384	Closed	-$8.48M	–	341
2020 Q4	$8.48M	Buy	41,384 +19,031	+85%	+$3.53M	0.07%	145
2020 Q3	$4.37M	Buy	+22,353	New	+$5.38M	0.05%	184

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCW Group's GOCO Position: Q1 2021 in Review

TCW Group sold out of GoHealth (GOCO) in Q1 2021, closing a stake of 41,384 shares — an estimated $8.48M sold.

TCW Group first reported a position in GOCO in Q3 2020 and held it in 2 quarters. The position peaked at $8.48M in Q4 2020. 109 funds tracked by Wall St. Rank hold GOCO as of Q1 2021.

TCW Group reported no remaining GoHealth position as of Q1 2021 after selling out during the quarter.
TCW Group sold 41,384 GoHealth shares in Q1 2021, an estimated $8.48M.
TCW Group first reported a position in GoHealth in Q3 2020 and held it in 2 quarters.
TCW Group's GoHealth position peaked at $8.48M in Q4 2020.
109 funds tracked by Wall St. Rank held GoHealth as of Q1 2021.

Based on TCW Group's 13F filing for Q1 2021, filed 5 May 2021.